Read our latest
news & insights.
Filter by type of content or theme.
Welcoming Martin Davis as BGV’s new Chairman
We’re excited to welcome Martin Davis as our new Chairman. Martin brings a deep understanding of how to scale investment firms with ambition and purpose. His expertise in strategy, fundraising, and organisational leadership will be instrumental as we take BGV into its next phase.
Gamifying finances for Gen Z: why we invested in Rule
We’re thrilled to announce that we’ve invested in portfolio company Rule’s pre-seed round, led by gaming-focused venture capital fund, London Venture Partners.
Unlocking the future of farming: why we invested in Ostara
We’re delighted to announce that we’ve led Ostara’s pre-seed round. Their software helps controlled environment farmers monitor, control, and optimise their operations in real-time.
Apply for the BGV Autumn 2025 Tech for Good Programme
We’re very pleased to announce that applications for our flagship Tech for Good programme for Autumn 2025 are open!
Rethinking urban retail logistics: why we invested in RideLogix
We’re really excited to announce our investment in RideLogix’s £500k pre-seed round. RideLogix is helping to make urban retail both more profitable and sustainable.
A new approach to identity verification: why we invested in Vouchsafe
We’re excited to share that we are leading Vouchsafe’s £1m pre-seed round. Vouchsafe are tackling the problem of 'ID poverty' head on.
Backing experienced operators and first-time founders alike
At BGV, we back ambitious founders from all walks of life, including experienced operators and first-time founders.
Three tips to apply for BGV’s Spring 2025 Programme
Applications for BGV’s Spring 2025 programme are now open, here are some tips to apply!
The State of WorkerTech
Launching the WorkerTech report - a market map showcasing WorkerTech ventures contributing to a fairer future of work for low- and middle-income Britain.
Meet the startups joining BGV’s Autumn 24 Programme
Meet the exciting tech for good ventures joining BGV's Autumn 2024 programme.
From BGV to successful exit: Aparito
From BGV to succesful exit to Big Pharma (via Wales). How Aparito’s Atom5 technology is revolutionising clinical trials.
No results found.
Please try different keywords.
